Parmax Pharma Market Cap ($5.07M USD)
Parmax Pharma Market Cap ($5.07M USD). As of Sept. 28, 2026, Parmax Pharma (PARMAX) market capitalisation is ₹45.61 Cr ($5.07M), with 33.11 L shares outstanding at a current price of ₹137.75 on BSE, ranking 3792 out of 5368 companies by market cap in our screener. Parmax Pharma operates in the Healthcare sector and is classified as a Small Cap stock. Compare with Parmax Pharma value estimation to assess whether the stock is under or overvalued.
Market Cap History of Parmax Pharma (Last 10 Years)
PARMAX market capitalisation from year-end BSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Parmax Pharma share price chart.
End of Year Market Cap History — Parmax Pharma
PARMAX year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Review PARMAX price earnings ratio to evaluate earnings-based valuation against sector peers.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹45.61 Cr
$5.07M USD
|
₹137.75 | BSE | +307.18% |
| 2025 |
₹11.20 Cr
$1.24M USD
|
₹33.83 | BSE | -23.55% |
| 2024 |
₹14.65 Cr
$1.63M USD
|
₹44.25 | BSE | +35.86% |
| 2023 |
₹10.78 Cr
$1.20M USD
|
₹32.57 | BSE | -15.84% |
| 2022 |
₹12.81 Cr
$1.42M USD
|
₹38.70 | BSE | -35.45% |
| 2021 |
₹19.85 Cr
$2.21M USD
|
₹59.95 | BSE | +103.22% |
| 2020 |
₹9.77 Cr
$1.09M USD
|
₹29.50 | BSE | +63.89% |
| 2019 |
₹5.96 Cr
$662,214 USD
|
₹18.00 | BSE | +4.05% |
| 2018 |
₹5.73 Cr
$636,461 USD
|
₹17.30 | BSE | +1.76% |
| 2017 |
₹5.63 Cr
$625,424 USD
|
₹17.00 | BSE | - |